کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6000932 1579206 2016 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Thrombophilia testing in young patients with ischemic stroke
ترجمه فارسی عنوان
ترومبوفیلی در بیماران جوان مبتلا به سکته مغزی ایسکمیک
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
چکیده انگلیسی


- Lupus anticoagulant was likely associated with ischemic stroke.
- Patients heterozygous for factor V Leiden had a significantly higher risk of TIA.
- Factors for atherosclerotic were frequent in young patients with ischemic stroke.

IntroductionThe possible significance of thrombophilia in ischemic stroke remains controversial. We aimed to study inherited and acquired thrombophilias as risk factors for ischemic stroke, transient ischemic attack (TIA) and amaurosis fugax in young patients.Materials and methodsWe included patients aged 18 to 50 years with ischemic stroke, TIA or amaurosis fugax referred to thrombophilia investigation at Aarhus University Hospital, Denmark from 1 January 2004 to 31 December 2012 (N = 685). Clinical information was obtained from the Danish Stroke Registry and medical records. Thrombophilia investigation results were obtained from the laboratory information system. Absolute thrombophilia prevalences and associated odds ratios (OR) with 95% confidence intervals (95% CI) were reported for ischemic stroke (N = 377) and TIA or amaurosis fugax (N = 308). Thrombophilia prevalences for the general population were obtained from published data.ResultsNo strong associations were found between thrombophilia and ischemic stroke, but patients with persistent presence of lupus anticoagulant (3%) had an OR at 2.66 (95% CI 0.84-9.15) for ischemic stroke. A significantly higher risk of TIA/amaurosis fugax was found for factor V Leiden heterozygote (12%) (OR: 1.99 (95% CI 1.14-3.28)). No other inherited or acquired thrombophilia was associated with ischemic stroke, TIA or amaurosis fugax.ConclusionsIn young patients, thrombophilia did not infer an increased risk of ischemic stroke. Only factor V Leiden heterozygote patients had an increased risk of TIA/amaurosis fugax, and persistent presence of lupus anticoagulant was likely associated with ischemic stroke. We suggest the testing restricted to investigation of persistent presence of lupus anticoagulant.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Thrombosis Research - Volume 137, January 2016, Pages 108-112
نویسندگان
, , ,